Delivery Order SPE2DB20D3304-SPE2DB26FW4K3
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Mounjaro 12.5 mg/0.5 mL pen injectors valued at $10,552.44 under a firm fixed-price contract. The product will be delivered to AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania, with an ultimate completion date of October 28, 2025. This delivery order was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Mounjaro 15 mg/0.5 ml pen injections, with a contract ceiling value of $2,720.90 and a completion date of June 26, 2025. This competitive, non-set-aside delivery order utilizes firm fixed pricing and represents a single pharmaceutical supply transaction under AmerisourceBergen's existing federal contract vehicle. The place of performance is listed as Conshohocken, Pennsylvania, which is also the company's...
- The Defense Logistics Agency awarded a delivery order valued at $3,326.28 to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 ml pen injections. This non-set-aside, competitively awarded contract was issued on September 9, 2025, with an ultimate completion date of September 10, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The firm fixed price delivery order represents a routine pharmaceutical procurement for military...
- The Defense Logistics Agency awarded a delivery order valued at $1,722.19 to AmerisourceBergen Drug Corp for Mounjaro 12.5 mg/0.5 mL pen injections on August 27, 2025, with an ultimate completion date of August 28, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,904.63 to AmerisourceBergen Drug Corp for the supply of Mounjaro 15 mg/0.5 ml pen injections on August 25, 2025, with completion scheduled for August 26, 2025. This competitively awarded, firm fixed-price delivery order represents a continuation of AmerisourceBergen's critical role as a pharmaceutical supplier to the federal government. The contract was executed without set-aside designation, indicating open competition among...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $17,344.53 for Mounjaro 7.5 mg/0.5 mL pen injections on October 21, 2025, with an ultimate completion date of October 22, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designations and will be performed at the contractor's Conshohocken, Pennsylvania location. The award represents a single transaction under AmerisourceBergen's larger pharmaceutical supply vehicle...
- The Defense Logistics Agency awarded a delivery order valued at $1,546.13 to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 ml pen injections on October 22, 2025, with completion scheduled for October 23, 2025. This is a firm fixed-price delivery order with no set-aside designation, placing performance at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award represents a single-line item transaction within AmerisourceBergen's broader pharmaceutical supply relationship with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Mounjaro 5 mg/0.5 ml pen injections valued at $1,707.87 with a firm fixed price structure. This non-set-aside competitive award was issued on October 22, 2025, with an ultimate completion date of October 23, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction fulfilling pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $4,647.49 to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 ml pen injections. This competitively awarded, firm fixed-price contract was executed on September 15, 2025, with an ultimate completion date of September 16, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under a larger contracting vehicle...
- The Defense Logistics Agency awarded a delivery order valued at $1,840.88 to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 ml pen injections, with a completion date of September 30, 2025. This firm fixed-price delivery order, issued as a non-competitive award, represents a single pharmaceutical procurement under AmerisourceBergen's broader supply relationship with DLA. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the...
- SPE2DB20D3304Indefinite Delivery Contract
- SPE2DB20D3304-SPE2DB26FW4K3Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,217.65 to AmerisourceBergen Drug Corp for the supply of Mounjaro 12.5 mg/0.5 mL pen injections. This firm fixed price, non-set-aside delivery order was awarded on October 30, 2025, with an ultimate completion date of October 31, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a standard pharmaceutical procurement supporting federal medical supply chain requirements. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's federal contracting history demonstrates consistent capability to meet competitive procurement requirements across multiple therapeutic domains, with delivery orders ranging from minimal to substantial values.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 10/30/25 |